-
Site License
-
Site License
-
Enterprisewide
-
Enterprisewide
In-vitro Diagnostics Market Outlook in Taiwan
Frost & Sullivan, March 2011, Pages: 98
This research service analyses the IVD market in Taiwan strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular testing, SMBG, and point-of-care testing, and forecast the same until 2017. Regional attractiveness is provided, and analysis based on competitive forces is performed. Together, the future market potential and opportunities in attractive segments are discussed in detai
Research Overview
This Frost & Sullivan research service titled In-vitro Diagnostics Market Outlook in Taiwan analyses the revenue potential for the key segments in this market until 2017. It analyses the regional attractiveness of the Taiwanese market based on competitive factors. The future market potential and opportunities in attractive segments are discussed in detail. In this research, Frost & Sullivan's expert analysts thoroughly examine the following application sectors: clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood glucose (SMBG) and point-of-care (POC) testing.
Market Overview
Taiwanese Government’s Initiatives to Improve the Quality of Healthcare to Propel the $252.0-Million IVD Market toward $381.0 Million in 2017
Efforts to Promote Taiwan as a Healthcare Hub Gain Momentum with the Implementation of Pro-Biotechnology Plans
With 2.46 million people aged above 65 in 2009, Taiwan is a hotbed of opportunities for healthcare services and subsequently, in-vitro diagnostics. The need for early diagnosis for the elderly and an expected rise in healthcare spending due to citizens’ desire for a healthy lifestyle and high-quality healthcare facilities will help the market grow at a stable compound annual growth rate of 6.1 per cent from 2010 to 2017. End users’ growing willingness to use advanced tests and products will drive manufacturers to constantly introduce novel tests. Biotech participants will also be buoyed by the continuous government support to standardise medical devices and initiatives to develop the country into a healthcare hub. For instance, the Government has implemented the ‘The Taiwan Diamond Plan for Biotechnology Development’ to encourage R&D, accumulate biotechnology venture capital (BVC) and aid start-up enterprises. “The Government intends to spend Taiwan new dollar (TND)1.27 billion during 2009-2014 in the biotechnology industry to encourage the growth of the social BVC from TND891 million in 2009 to TND1.78 billion in 2014,” says the analyst of this research. “Through this plan, it hopes to increase the value of the biotechnology industry from TND4.29 billion in 2009 to TND8.58 billion in 2014.”
Despite such robust Government backing, the low clarity on the reimbursement coverage for molecular tests will impede the market’s growth. Further, intellectual property (IP) issues and legal challenges deter foreign companies from setting up their R&D centres in Taiwan. Local companies also have reasons to feel disgruntled, as the success of their innovative tests depends on insurance coverage. “Strategic collaborations between local and international companies to develop cost-effective tests and innovative products offset their challenges to a great extent,” notes the analyst. “The establishment of the Taiwan Food and Drug Administration (TFDA) to regulate standards will help local companies launch their products efficiently in the country.” The TFDA will also serve as a springboard for the global market, as the Government is hoping to establish regulations that will meet international standards.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Clinical chemistry
- Immunoassay
- Hematology
- Coagulation
- Microbiology
- Molecular diagnostics
- Self monitoring of blood glucose
- Point-of-care testing
1. Executive Summary
2. Research Overview
3. Introduction
4. Healthcare Structure –Taiwan
5. IVD Products –Approval, Reimbursement and Procurement
6. Definition and Abbreviations
7. Scope and Segmentation
8. Industry Challenges
9. Analysis of the IVD Market in Taiwan –Current Scenario
10. Market Drivers and Restraints
11. Market Engineering Measurements
12. Market Life Cycle
13. Revenue Forecasts –Total IVD Market
14. Percent of Revenues by Segment
15. Revenue Forecasts –Clinical Chemistry Market
16. Clinical Chemistry Market –Current Status
17. Revenue Forecasts –Immunoassay Market
18. Immunoassay Market –Current Status
19. Revenue Forecasts –Haematology Market
20. Haematology Market –Current Status
21. Revenue Forecasts –Coagulation Market
22. Coagulation Market –Current Status
23. Revenue Forecasts –Microbiology Market
24. Microbiology Market –Current Status
25. Revenue Forecasts –Molecular Testing Market
26. Molecular Testing Market –Current Status
27. Revenue Forecasts –SMBG Market
28. SMBG Market –Current Status
29. Revenue Forecasts –POCT Market
30. POCT Market –Current Status
31. Competitive Structure
32. Competitive Scenario
33. Competitive Forces
34. Market Share Analysis
35. IVD Business in Taiwan –Past, Present and Future
36. Customer Priorities Trajectory
37. Snapshot of Potential Opportunities
38. Market Attractiveness
39. Opportunities in Attractive Segments
40. Key Trends and Opportunities
41. Impact of Top Five Trends on the Market Growth
42. Conclusion and Recommendations
43. Database of Key Participants –Manufacturers and Distributors
44. List of Major Laboratories with Location
45. About Frost & Sullivan
List of Figures
- Total IVD Market: Revenue Forecasts (Taiwan), 2007-2017
- Clinical Chemistry Market: Revenue Forecasts (Taiwan), 2007-2017
- Immunoassay Market: Revenue Forecasts (Taiwan), 2007-2017
- Hematology Market: Revenue Forecasts (Taiwan), 2007-2017
- Coagulation Market: Revenue Forecasts (Taiwan), 2007-2017
- Microbiology Market: Revenue Forecasts (Taiwan), 2007-2017
- Molecular Diagnostics Market: Revenue Forecasts (Taiwan), 2007-2017
- SMBG Market: Revenue Forecasts (Taiwan), 2007-2017
- POCT Market: Revenue Forecasts (Taiwan), 2007-2017
- Total IVD Market: Market Share Based on the Revenues of Top Three Participants (Taiwan), 2010
List Of Charts:
- Total IVD Market: Revenue Forecasts (Taiwan), 2007-2017
- Total IVD Market: Healthcare Financing System (Taiwan), 2009
- Total IVD Market: Healthcare System (Taiwan), 2010
- Total IVD Market: Impact of Industry Challenges (Taiwan), 2011-2017
- Total IVD Market: Market Drivers and Restraints (Taiwan), 2011-2017
- Total IVD Market: Market Drivers and Its Impact (Taiwan), 2011-2017
- Total IVD Market: Market Restraints and Its Impact (Taiwan), 2011-2017
- Total IVD Market: Market Engineering Measurements (Taiwan), 2010
- Total IVD Market: Market Life Cycle (Taiwan), 2011-2017
- Total IVD Market: Revenue Forecasts (Taiwan), 2007-2017
- Total IVD Market: Percent of Revenues by Segment (Taiwan), 2010
- Clinical Chemistry Market: Revenue Forecasts (Taiwan), 2007-2017
- Immunoassay Market: Revenue Forecasts (Taiwan), 2007-2017
- Hematology Market: Revenue Forecasts (Taiwan), 2007-2017
- Coagulation Market: Revenue Forecasts (Taiwan), 2007-2017
- Microbiology Market: Revenue Forecasts (Taiwan), 2007-2017
- Molecular Testing Market: Revenue Forecasts (Taiwan), 2007-2017
- SMBG Market: Revenue Forecasts (Taiwan), 2007-2017
- POCT Market: Revenue Forecasts (Taiwan), 2007-2017
- Total IVD Market: Competitive Forces (Taiwan), 2010
- Total IVD Market: Past, Present and Future (Taiwan), 2010
- Total IVD Market: Customer Priorities (Taiwan), 2010
- Total IVD Market: Snapshot of Potential Opportunities (Taiwan), 2011-2017
- Total IVD Market: Market Attractiveness (Taiwan), 2011-2017
- Total IVD Market: Impact of Top Five Trends on the Market Growth (Taiwan), 2011-2017
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
